Medigus Ltd Stock News

ParaZero’s unique patented technology designed to prevent drone crashes and losses

Israel-based Medigus Ltd (NASDAQ: MDGS ) and its wholly-owned subsidiary, Charging Robotics, have signed a non-binding letter of intent for a planned securities exchange agreement with Fuel … Full story available on Benzinga.com

Charging Robotics signs LOI to complete reverse merger on OTC Markets

Tel Aviv, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (�

Tel Aviv, Israel, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle an

Medigus (MDGS) purchased ~40% of an Israeli drone technology firm with a patented safety system for drones.The drone company developed a patented safety system designed to protect

The drone company's patented technology is a unique solution to prevent drone crashes and losses

Tel Aviv, Israel, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle an

Tel Aviv, Israel, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that an interview with Chairman Eli Yoresh and Vice President of Strategy and Business Development Yaki Baranes will air on The RedChip Money Report® on Bloomberg TV, Jan. 29, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the United States. The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years'' experience focused on Discovering Tomorrow''s Blue Chips Today. "The RedChip Money Report®" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. To view the Full story available on Benzinga.com

Tel Aviv, Israel, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and

REHOVOT, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced the appointment of Ori Hershkovitz, a long-time life sciences industry investor, to its Board of Directors. "We are thrilled to welcome Ori to the Purple Biotech Board of Directors," said Dr. Eric Rowinsky, Chairman of the Board of Purple Biotech. "Ori has spent many years investing in and advising development-stage life sciences companies. We look forward to leveraging his industry and financial expertise as we continue to execute on our corporate growth initiatives." "Purple Biotech has a compelling oncology-focused pipeline, highlighted by CM24 and NT219, with a great potential to transform the therapeutic options of many cancer patients," said Mr. Hershkovitz. "I look forward to working with the other members of the Board and the Company''s experienced management team to support Purple Biotech''s continued development and to drive long-term shareholder value." Mr.

In recent pre-clinical studies, Polyrizon products demonstrated a great potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhib